Mark Feldberg is listed as a director on 2 SEC Form D filings by 2 issuers between Mar 2015 and Dec 2015: ASAPP, Inc. (New York, NY — other technology — 2015; $117.8M reported sold to 56 investors) and Ovid Therapeutics Inc. (New York, NY — other health care — 2015; $75M reported sold to 50 investors).
What this means 2 separate companies raised money with this person listed as director. Across those companies the filings report $192.8M sold in total.
Listed alongside David Strohm (1 shared filing), Gustavo Sapoznik (1 shared filing), Jeremy M. Levin (1 shared filing) and Matthew J. During (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mark. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Mark Feldberg and found 2 differences, 1 worth asking the sponsor about: Form D filed 159 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.